Clinical Trials Sponsored by Taiho Pharmaceuticals

Total 19712 results

Taiho Oncology, Inc.
Taiho Pharmaceutical Co., Ltd.

Terminated

A Phase 2 Study Comparing TAS-102 Versus Topotecan or Amrubicin to Treat Small Cell Lung Cancer Following Platinum-Based Chemotherapy

Small Cell Lung Cancer (SCLC)

Japan, Italy, Germany
Taiho Pharmaceutical Co., Ltd.

Recruiting

A Study of TAS3731 in Healthy Adults

Healthy Adult Males

Japan
Taiho Pharmaceutical Co., Ltd.

Recruiting

A Phase 3 Study of TAS-205 in Patients With Duchenne Muscular Dystrophy（REACH-DMD）

Duchenne Muscular Dystrophy

Japan
Taiho Pharmaceutical Co., Ltd.

Completed

Study of Trifluridine/Tipiracil (TAS-102) in Patients With Metastatic Colorectal Cancer in Asia (TERRA)

Colorectal Cancer

Korea, Republic of, China, Thailand
Taiho Pharmaceutical Co., Ltd.

Completed

Exploratory Study of TAC-302 in Detrusor Underactivity Patients With Overactive Bladder.

Overactive Bladder | Detrusor Underactivity

Japan
Taiho Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety Study of TAS5315 Compared With Placebo in Participants With Rheumatoid Arthritis.

Rheumatoid Arthritis

Japan
Taiho Pharmaceutical Co., Ltd.

Completed

A Phase I Study of TAS-102 in Solid Tumors

Advanced or Metastatic Solid Tumors

China
Taiho Pharmaceutical Co., Ltd.

Completed

Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal Cancer

Colorectal, Cancer

Japan
Taiho Pharmaceutical Co., Ltd.

Completed

Phase I/II Study of TSU-68 for Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma

Japan
Taiho Pharmaceutical Co., Ltd.

Completed

Phase II Study of ABI-007 for Gastric Cancer

Gastric Cancer

Japan
Taiho Pharmaceutical Co., Ltd.

Completed

Comparative Study of Palonosetron With Granisetron as a Control in Patients Receiving Highly Emetogenic Chemotherapy

Chemotherapy-Induced Nausea and Vomiting

Japan
Taiho Pharmaceutical Co., Ltd.

Completed

Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer

Gastric Cancer

China
Taiho Pharmaceutical Co., Ltd.

Completed

Randomized Phase III Study of TS-1 Alone Versus TS-1 Plus CDDP in Advanced Gastric Cancer

Gastric Cancer

Japan
Taiho Pharmaceutical Co., Ltd.

Recruiting

A Phase 2a Study of TAS5315 in Patients With Chronic Spontaneous Urticaria

Chronic Spontaneous Urticaria

Japan
Taiho Pharmaceutical Co., Ltd.

Recruiting

AB122 Platform Study

Gastric Cancer | Colorectal Cancer | Non-small Cell Lung Cancer | Pancreatic Ductal Adenocarcinoma | Alveolar Soft Part Sarcoma | Advanced or Metastatic Solid Tumor

Japan
Taiho Pharmaceutical Co., Ltd.

Completed

A Phase 2 Study of TAS-303 in Female Patients With Stress Urinary Incontinence

Stress Urinary Incontinence

Japan
Taiho Pharmaceutical Co., Ltd.

Completed

A Study of TAS-205 for Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy

Japan
Taiho Pharmaceutical Co., Ltd.

Completed

Phase II Trial of Combination Therapy With Irinotecan, S-1, and Bevacizumab (IRIS/Bev) in Patients With Unresectable or Recurrent Colorectal Cancer

Colorectal Cancer

Japan
Taiho Pharmaceutical Co., Ltd.

Completed

Phase II Trial of Combination Therapy With Bevacizumab and S-1 in Elderly Patients With Unresectable or Recurrent Colorectal Cancer (BASIC)

Colorectal Cancer

Japan
Taiho Pharmaceutical Co., Ltd.

Terminated

Phase II Study of TAS-109 to Treat Advanced Colorectal Cancer

Advanced Colorectal Cancer

United States
Taiho Pharmaceutical Co., Ltd.

Completed

A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC)

Breast Cancer

Japan
Taiho Pharmaceutical Co., Ltd.

Completed

A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC)

Colorectal Cancer

Japan
Taiho Pharmaceutical Co., Ltd.

Completed

A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC)

Gastric Cancer

Japan
Taiho Pharmaceutical Co., Ltd.

Recruiting

A Study of Pimitespib in Combination With Imatinib in Patients With GIST (CHAPTER-GIST-101)

Gastrointestinal Stromal Tumors

Taiwan, Japan, China, Australia, Singapore
Taiho Pharmaceutical Co., Ltd.

Completed

A Mass Balance Study of [14C] TAS-303 in Healthy Adult Male Subjects

Healthy Male Subjects

Japan
Taiho Pharmaceutical Co., Ltd.

Completed

Mass Balance Study of [14C] TAS-205 in Healthy Volunteers

Healthy Male Subjects

Japan
Taiho Pharmaceutical Co., Ltd.

Completed

A Phase IIa Study of TAS-205 for Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy

Japan
Taiho Pharmaceutical Co., Ltd.

Terminated

Orantinib In Combination With Transcatheter Arterial Chemoembolization In Patients With Unresectable Hepatocellular Carcinoma (ORIENTAL)

Hepatocellular Carcinoma

Korea, Republic of, Taiwan, Japan
Taiho Pharmaceutical Co., Ltd.

Completed

Phase III Study of S-1 + Cisplatin vs Cisplatin in Cervical Cancer

Cervical Cancer

Japan, Korea, Republic of, Taiwan
Taiho Pharmaceutical Co., Ltd.

Completed

Exploratory Trial of TAS-303 in Female Patients With Stress Urinary Incontinence

Stress Urinary Incontinence

Japan
Taiho Pharmaceutical Co., Ltd.

Completed

A Study of TAS-114 in Combination With S-1 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

Japan
Taiho Pharmaceutical Co., Ltd.

Completed

A Study of TAS-303 in Female Patients With Stress Urinary Incontinence

Stress Urinary Incontinence

Japan
Taiho Pharmaceutical Co., Ltd.

Terminated

Phase II Study of TAS-106 to Treat Head and Neck Cancer

Head and Neck Cancer

United States, Hong Kong, Singapore, Taiwan
Taiho Pharmaceutical Co., Ltd.

Completed

Study of S-1 Plus LV for Untreated Metastatic Colorectal Cancer

Colorectal Cancer

China, Japan
Taiho Pharmaceutical Co., Ltd.

Completed

Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC)

Gastric Cancer

Japan
Taiho Pharmaceutical Co., Ltd.

Completed

The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC)

Breast Cancer

Japan
Sanofi
Taiho Pharmaceutical Co., Ltd.

Terminated

S-1 Versus 5-FU Bolus in Metastatic Pancreatic Cancer Patients Previously Treated With Gemcitabine-Based Regimen (S-1 Pancreas)

Neoplasm Metastasis | Pancreatic Neoplasm

United States, France, Canada, Brazil, Romania, Sweden, Tunisia, Austria, Denmark, Hungary, Peru, South Africa, Greece, Costa Rica, Israel, Guatemala, Panama
TAHO Pharmaceuticals Ltd.

Completed

Comparative Bioavailability Study of TAH3311 5 mg Oral Dissolving Film vs ELIQUIS® 5 mg Tablet in Healthy Volunteers (TAH-12288201)

Healthy Volunteers | Fasting | Fed

United States
Peking University
Taiho Pharmaceutical Co., Ltd.

Unknown

SOX Sequential S-1 in Advanced Biliary Tract Carcinoma（BTC）and Pancreatic Cancer

Pancreatic Cancer | Biliary Tract Cancer | Periampullary Adenocarcinoma

China
Taisho Pharmaceutical Co., Ltd.

Completed

Phase III Study of TS-142 in Patients With Insomnia

Patients With Insomnia

Japan
Taisho Pharmaceutical Co., Ltd.

Completed

Safety, Pharmacokinetic, and Pharmacodynamic Study of TS-142 in Healthy Subjects

Healthy Volunteer

Japan
Taisho Pharmaceutical Co., Ltd.

Completed

A Phase I Study of TS-142 in Healthy Participants (Repeated Doses)

Healthy Volunteer

Japan
Taisho Pharmaceutical Co., Ltd.

Completed

A Phase I Study of TS-142 in Healthy Participants (Single Doses)

Healthy Volunteer

Japan
Taisho Pharmaceutical Co., Ltd.

Completed

Clinical Study of TS-143 in Healthy Adult Male Subjects (Single-Dose Administration)

Healthy Participants

Japan
Taisho Pharmaceutical Co., Ltd.

Completed

A Food Effect Study of TS-142 in Healthy Subjects

Effect of Food

Japan
Taisho Pharmaceutical Co., Ltd.

Completed

Clinical Study of TS-143 in Healthy Adult Male Subjects (Multiple-Dose Administration)

Healthy Participants

Japan
Taisho Pharmaceutical Co., Ltd.

Completed

Clinical Study on Histamine H3 Receptor Occupancy of TS-091 by PET Examination in Healthy Adult Subjects

Healthy Subjects

Japan
Taisho Pharmaceutical Co., Ltd.

Completed

A Study Of The Effect Of PF-04802540 On Sleep Measures

Healthy

United States
Taiko Pharmaceutical Co., Ltd.

Unknown

Test of a Preventive Effect of a Deodorant Device Against Respiratory Infections (Cleverin)

Respiratory Infection

Japan
Peking University
Taiho Pharmaceutical Co., Ltd.

Unknown

Phase III Study to Compare Perioperative Chemotherapy of Oxaliplatin Combined With S-1(SOX) Versus SOX or Oxaliplatin With Capecitabine (XELOX) as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma With D2 Dissection

Advanced Gastric Carcinoma

China

Clinical Trials Sponsored by Taiho Pharmaceuticals

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations